Literature DB >> 16437490

Perioperative ketamine for acute postoperative pain.

R F Bell1, J B Dahl, R A Moore, E Kalso.   

Abstract

BACKGROUND: Postoperative pain management is often limited by adverse effects such as nausea and vomiting. Adjuvant treatment with an inexpensive opioid-sparing drug such as ketamine may be of value in giving better analgesia with fewer adverse effects.
OBJECTIVES: To evaluate the effectiveness and tolerability of ketamine administered perioperatively in the treatment of acute postoperative pain in adults. SEARCH STRATEGY: Studies were identified from MEDLINE (1966-2004), EMBASE (1980-2004), the Cochrane Library (2004) and by handsearching reference lists from review articles and trials. The manufacturer of ketamine (Pfizer) provided search results from their in-house database, PARDLARS. SELECTION CRITERIA: Randomised controlled trials (RCTs) of adult patients undergoing surgery, being treated with perioperative ketamine or placebo. Studies where ketamine was administered in addition to a basic analgesic (such as morphine or NSAID) in one study group, and compared with a group receiving the same basic analgesic (but without ketamine) in another group, were also included. DATA COLLECTION AND ANALYSIS: Two independent reviewers identified fifty five RCTs for potential inclusion. Quality and validity assessment was performed by two independent reviewers. In the case of discrepancy, a third reviewer was consulted. Patient reported pain intensity and pain relief was assessed using visual analogue scales or verbal rating scales and adverse effects data were collated. MAIN
RESULTS: Thirty-seven trials were included (2240 participants). Eighteen trials were excluded.Twenty-seven of the 37 trials found that perioperative subanaesthetic doses of ketamine reduced rescue analgesic requirements or pain intensity, or both. Quantitative analysis showed that treatment with ketamine reduced 24 hour PCA morphine consumption and postoperative nausea or vomiting (PONV). Adverse effects were mild or absent. AUTHORS'
CONCLUSIONS: Ketamine in subanaesthetic dose (that is a dose which is below that required to produce anaesthesia) is effective in reducing morphine requirements in the first 24 hours after surgery. Ketamine also reduces postoperative nausea and vomiting. Adverse effects are mild or absent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16437490     DOI: 10.1002/14651858.CD004603.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  71 in total

1.  Direct administration of ifenprodil and citalopram into the nucleus accumbens inhibits cue-induced nicotine seeking and associated glutamatergic plasticity.

Authors:  Jonna M Leyrer-Jackson; Jose A Piña; Joseph McCallum; M Foster Olive; Cassandra D Gipson
Journal:  Brain Struct Funct       Date:  2020-06-26       Impact factor: 3.270

2.  Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.

Authors:  Samuel Fanta; Mari Kinnunen; Janne T Backman; Eija Kalso
Journal:  Eur J Clin Pharmacol       Date:  2015-03-01       Impact factor: 2.953

Review 3.  [Pain management of burn injuries].

Authors:  R Girtler; B Gustorff
Journal:  Anaesthesist       Date:  2011-03       Impact factor: 1.041

Review 4.  Enhanced recovery pathways in thoracic surgery from Italian VATS Group: perioperative analgesia protocols.

Authors:  Federico Piccioni; Matteo Segat; Stefano Falini; Marzia Umari; Olga Putina; Lucio Cavaliere; Riccardo Ragazzi; Domenico Massullo; Marco Taurchini; Carlo Del Naja; Andrea Droghetti
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  [New and evidence-based aspects of postoperative pain therapy].

Authors:  T Volk
Journal:  Orthopade       Date:  2008-10       Impact factor: 1.087

Review 6.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

Review 7.  The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse.

Authors:  Ellen M Soffin; Bradley H Lee; Kanupriya K Kumar; Christopher L Wu
Journal:  Br J Anaesth       Date:  2018-12-28       Impact factor: 9.166

Review 8.  [Remifentanil-based intraoperative anaesthesia and postoperative pain therapy. Is there an optimal treatment strategy?].

Authors:  C Zöllner; M Schäfer
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

Review 9.  Recent advances in postoperative pain management.

Authors:  Nalini Vadivelu; Sukanya Mitra; Deepak Narayan
Journal:  Yale J Biol Med       Date:  2010-03

10.  Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.

Authors:  Jörg Martin; Anja Heymann; Katrin Bäsell; Ralf Baron; Rolf Biniek; Hartmut Bürkle; Peter Dall; Christine Dictus; Verena Eggers; Ingolf Eichler; Lothar Engelmann; Lars Garten; Wolfgang Hartl; Ulrike Haase; Ralf Huth; Paul Kessler; Stefan Kleinschmidt; Wolfgang Koppert; Franz-Josef Kretz; Heinz Laubenthal; Guenter Marggraf; Andreas Meiser; Edmund Neugebauer; Ulrike Neuhaus; Christian Putensen; Michael Quintel; Alexander Reske; Bernard Roth; Jens Scholz; Stefan Schröder; Dierk Schreiter; Jürgen Schüttler; Gerhard Schwarzmann; Robert Stingele; Peter Tonner; Philip Tränkle; Rolf Detlef Treede; Tomislav Trupkovic; Michael Tryba; Frank Wappler; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2010-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.